Montara Therapeutics

Montara Therapeutics is a preclinical-stage biopharmaceutical company dedicated to developing safer and more effective treatments for neurological disorders through novel approaches. Montara's BrainOnly platform enables brain-specific pharmacological research using existing and novel chemical leads, limiting harmful off-target peripheral activity. BrainOnly has the potential to drug many targets previously considered undruggable.